Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trans Genic is a Japanese biotechnology company that provides essential research tools and services for drug discovery and life sciences. The company is a leader in the production of genetically modified mouse models, including knockout and transgenic mice, utilizing its proprietary GANP mouse technology for high-affinity antibody generation. In addition to animal models, Trans Genic offers a wide range of contract research services (CRO) such as pathological analysis, safety testing, and genomic analysis through its group subsidiaries. The company also engages in the development of diagnostic reagents and therapeutic antibody candidates for oncology and inflammatory diseases. By integrating its expertise in genomics and proteomics, Trans Genic supports pharmaceutical companies and academic institutions globally in accelerating their R&D pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trans Genic.